Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin.

MLA

Hiramatsu, N., et al. “Ribavirin Dose Reduction Raises Relapse Rate Dose-Dependently in Genotype 1 Patients with Hepatitis C Responding to Pegylated Interferon Alpha-2b plus Ribavirin.” Journal of Viral Hepatitis, vol. 16, no. 8, Aug. 2009, pp. 586–94. EBSCOhost, https://doi.org/10.1111/j.1365-2893.2009.01106.x.

APA

Hiramatsu, N., Oze, T., Yakushijin, T., Inoue, Y., Igura, T., Mochizuki, K., Imanaka, K., Kaneko, A., Oshita, M., Hagiwara, H., Mita, E., Nagase, T., Ito, T., Inui, Y., Hijioka, T., Katayama, K., Tamura, S., Yoshihara, H., Imai, Y., & Kato, M. (2009). Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin. Journal of Viral Hepatitis, 16(8), 586–594. https://doi.org/10.1111/j.1365-2893.2009.01106.x

Chicago

Hiramatsu, N., T. Oze, T. Yakushijin, Y. Inoue, T. Igura, K. Mochizuki, K. Imanaka, et al. 2009. “Ribavirin Dose Reduction Raises Relapse Rate Dose-Dependently in Genotype 1 Patients with Hepatitis C Responding to Pegylated Interferon Alpha-2b plus Ribavirin.” Journal of Viral Hepatitis 16 (8): 586–94. doi:10.1111/j.1365-2893.2009.01106.x.